Have you been diagnosed with a brain tumour? Order your free information pack.

Our Scientific and Lay Advisors

In order to ensure that we fund only the highest quality research, we have formed Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.

The lay members of our SABs represent people personally affected by a brain tumour, ensuring that our community’s interests remain at the forefront of our grant award process.

The boards are responsible for the assessment and rating of applications for research funding and making recommendations to our Board of Trustees. Find out a little about them below.

Biomedical Scientific Advisory Board (Biomed SAB)

The Biomedical SAB assess applications from grant rounds that focus on scientific, clinical or translational research. The funding applications they assess primarily work towards achieving our goal of Doubling Survival.

Lay Advisory Board Members

Our commitment to our beneficiaries is crucial to us and as such, we feel that it is important to allow our community the opportunity to use their personal experience of the disease to contribute to the research grant awarding process. Hence, we also have five lay representatives who are a part of the SABs to provide their expert-by-experience perspective on whether the applications that we receive for funding are important and/or feasible for patients. Find out a little more about them below.

Low Grade Center SAB

These advisors have been chosen specially for their expertise in disciplines being used at our Paediatric Low Grade Brain Tumour Research Centre. They're helping us ensure that our research into low grade tumours is progressing in the best possible way.

Clinical Trial SAB

These advisors have been chosen for their expertise in clinical trials and relevant disciplines. They are helping us make sure we fund clinical trials urgently needed by the community. The Clinical Trial SAB has reviewed one-off funding opportunities for the Cannabinoid Clinical Trial and the Paediatric High Grade Glioma Clinical Trial.

Other Advisors

These scientists and clinicians are part of a wider group of people who are key to achieving our goals of doubling survival and halving the harm. They fill various roles by sharing their knowledge and experience with us and we are indebted to them for this.

We’re raising the benchmark

We’ve been recognised as Charity of the Year 2018 for our pioneering approach, innovative research solutions and, above all, our community-centred approach to everything we do.